U.S. Food and Drug Administration Updates CAMZYOS\u00ae (mavacamten) Label to Reduce Echocardiography Monitoring Requirements an

• click to rate

  Posted by Two Blokes Apr 18 - Filed in Stock - 5 views
  
  PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CAMZYOS--U.S. Food and Drug Administration Updates CAMZYOS\u00ae (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications.